https://www.selleckchem.com/products/nb-598.html
27 ± 0.60D, p = 0.04) and more improvement in BSCVA (mean difference 0.08 ± 0.02 logMAR, p 0.001) compared to the paracentral group. There was no significant difference in progression rates between the central and paracentral groups (ΔKmax 2D, 6.7% vs. 6.5%, respectively, p = 0.83). This large-scale study of keratoconus eyes 1 year after accelerated CXL indicates that compared to those with paracentral cones, central cones have on average almost one additional line improvement in BCSVA and 1.27 D more reduction in myopia. This
Curtir
Comentario
Compartilhar
